Hooper A - Search Results

1

Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors.

Prewett M, Huber J, Li Y, Santiago A, O'Connor W, King K, Overholser J, Hooper A, Pytowski B, Witte L, Bohlen P, Hicklin DJ. Prewett M, et al. Among authors: hooper a. Cancer Res. 1999 Oct 15;59(20):5209-18. Cancer Res. 1999. PMID: 10537299

2

Anti-epidermal growth factor receptor monoclonal antibody cetuximab inhibits EGFR/HER-2 heterodimerization and activation.

Patel D, Bassi R, Hooper A, Prewett M, Hicklin DJ, Kang X. Patel D, et al. Among authors: hooper a. Int J Oncol. 2009 Jan;34(1):25-32. Int J Oncol. 2009. PMID: 19082474

3

Enhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenografts.

Prewett MC, Hooper AT, Bassi R, Ellis LM, Waksal HW, Hicklin DJ. Prewett MC, et al. Clin Cancer Res. 2002 May;8(5):994-1003. Clin Cancer Res. 2002. PMID: 12006511

4

Active immunization against the vascular endothelial growth factor receptor flk1 inhibits tumor angiogenesis and metastasis.

Li Y, Wang MN, Li H, King KD, Bassi R, Sun H, Santiago A, Hooper AT, Bohlen P, Hicklin DJ. Li Y, et al. Among authors: hooper at. J Exp Med. 2002 Jun 17;195(12):1575-84. doi: 10.1084/jem.20020072. J Exp Med. 2002. PMID: 12070285 Free PMC article.

5

A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.

Burtrum D, Zhu Z, Lu D, Anderson DM, Prewett M, Pereira DS, Bassi R, Abdullah R, Hooper AT, Koo H, Jimenez X, Johnson D, Apblett R, Kussie P, Bohlen P, Witte L, Hicklin DJ, Ludwig DL. Burtrum D, et al. Cancer Res. 2003 Dec 15;63(24):8912-21. Cancer Res. 2003. PMID: 14695208

6

Fetal stromal-dependent paracrine and intracrine vascular endothelial growth factor-a/vascular endothelial growth factor receptor-1 signaling promotes proliferation and motility of human primary myeloma cells.

Vincent L, Jin DK, Karajannis MA, Shido K, Hooper AT, Rashbaum WK, Pytowski B, Wu Y, Hicklin DJ, Zhu Z, Bohlen P, Niesvizky R, Rafii S. Vincent L, et al. Among authors: hooper at. Cancer Res. 2005 Apr 15;65(8):3185-92. doi: 10.1158/0008-5472.CAN-04-3598. Cancer Res. 2005. PMID: 15833849

7

The vascular endothelial growth factor receptor (VEGFR-1) supports growth and survival of human breast carcinoma.

Wu Y, Hooper AT, Zhong Z, Witte L, Bohlen P, Rafii S, Hicklin DJ. Wu Y, et al. Int J Cancer. 2006 Oct 1;119(7):1519-29. doi: 10.1002/ijc.21865. Int J Cancer. 2006. PMID: 16671089

8

Enhanced suppression of melanoma tumor growth and metastasis by combined therapy with anti-VEGF receptor and anti-TYRP-1/gp75 monoclonal antibodies.

Patel D, Bassi R, Hooper AT, Sun H, Huber J, Hicklin DJ, Kang X. Patel D, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2679-86. Anticancer Res. 2008. PMID: 19035294 Free article.

9

Epidermal growth factor receptor blockade by antibody IMC-C225 inhibits growth of a human pancreatic carcinoma xenograft in nude mice.

Overholser JP, Prewett MC, Hooper AT, Waksal HW, Hicklin DJ. Overholser JP, et al. Among authors: hooper at. Cancer. 2000 Jul 1;89(1):74-82. Cancer. 2000. PMID: 10897003

10

Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis.

Liao F, Li Y, O'Connor W, Zanetta L, Bassi R, Santiago A, Overholser J, Hooper A, Mignatti P, Dejana E, Hicklin DJ, Bohlen P. Liao F, et al. Among authors: hooper a. Cancer Res. 2000 Dec 15;60(24):6805-10. Cancer Res. 2000. PMID: 11156369

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

539 results

Search Page

Filters